Jushi Holdings (JUSHF) Gains from Investment Securities (2021 - 2026)
Jushi Holdings (JUSHF) reported Gains from Investment Securities of -$15000.0 for Q1 2026, down 102.56% year-over-year from $586000.0 in Q1 2025, and up 99.79% quarter-over-quarter from -$7.3 million in Q4 2025.
Jushi Holdings (JUSHF) Gains from Investment Securities (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 6 years of Gains from Investment Securities data on file, last reported at -$15000.0 in Q1 2026.
- Gains from Investment Securities for Q1 2026 came in at -$15000.0, down 102.56% year-over-year; the trailing twelve-month figure through Mar 2026 was -$4.5 million (down 285.02% YoY), and the FY2025 annual result was -$3.9 million, down 294.33% from the prior year.
- Gains from Investment Securities climbed to -$15000.0 in Q1 2026 per JUSHF's latest filing, from -$7.3 million in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $6.7 million in Q4 2022 and troughed at -$7.3 million in Q4 2025.
- A 5-year average of $353812.5 and a median of $329500.0 in 2023 frame the typical range for Gains from Investment Securities.
- On a YoY basis, Gains from Investment Securities climbed as much as 2915.55% in 2022 and fell as far as 1187.62% in 2022.
- A 5-year view of Gains from Investment Securities shows it stood at $6.7 million in 2022, then sank by 105.45% to -$365000.0 in 2023, then surged by 1705.21% to $5.9 million in 2024, then plunged by 224.46% to -$7.3 million in 2025, then soared by 99.79% to -$15000.0 in 2026.
- Business Quant data shows JUSHF's Gains from Investment Securities at -$15000.0 in Q1 2026, -$7.3 million in Q4 2025, and $2.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Jushi Holdings | - | - | 29.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15,000.00 |
| Mar 31, 2026 | -15,000.00 |
| Dec 31, 2025 | -7.29 Mn |
| Dec 31, 2025 | -7.29 Mn |
| Sep 30, 2025 | 2.82 Mn |
| Sep 30, 2025 | 2.82 Mn |
| Jun 30, 2025 | -55,000.00 |
| Jun 30, 2025 | -55,000.00 |
| Mar 31, 2025 | 586,000.00 |
| Mar 31, 2025 | 586,000.00 |
| Dec 31, 2024 | 5.86 Mn |
| Dec 31, 2024 | 5.86 Mn |
| Sep 30, 2024 | -5.43 Mn |
| Sep 30, 2024 | -5.43 Mn |
| Jun 30, 2024 | 1.44 Mn |
| Jun 30, 2024 | 1.44 Mn |
| Mar 31, 2024 | 159,000.00 |
| Mar 31, 2024 | 159,000.00 |
| Dec 31, 2023 | -365,000.00 |
| Dec 31, 2023 | -365,000.00 |